LIS
SUPN icon

Legacy Investment Solutions’s Supernus Pharmaceuticals SUPN Stock Holding History

Legacy Investment Solutions’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$253 Buy
+8
New +$256 ﹤0.01% 695
2024
Q4 		$308 Hold
8
– – ﹤0.01% 696
2024
Q3 		$303 Buy
+8
New +$250 ﹤0.01% 646

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Legacy Investment Solutions's SUPN Position: Q2 2025 in Review

Legacy Investment Solutions opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2025: 8 shares worth $253. The stake represents ﹤0.01% of the portfolio and ranks #695 among its holdings. This is a return to the name: Legacy Investment Solutions previously reported a position in SUPN as recently as Q4 2024.

Legacy Investment Solutions first reported a position in SUPN in Q3 2024 and has held it in 3 quarters since. The position peaked at $308 in Q4 2024. 295 funds tracked by Wall St. Rank hold SUPN as of Q2 2025.

  • Legacy Investment Solutions held 8 shares of Supernus Pharmaceuticals worth $253 as of Q2 2025.
  • Supernus Pharmaceuticals was a new Legacy Investment Solutions position in Q2 2025.
  • Supernus Pharmaceuticals made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q2 2025, its #695 holding.
  • Legacy Investment Solutions first reported a position in Supernus Pharmaceuticals in Q3 2024 and has held it in 3 quarters since.
  • Legacy Investment Solutions's Supernus Pharmaceuticals position peaked at $308 in Q4 2024.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2025.

Based on Legacy Investment Solutions's 13F filing for Q2 2025, filed 6 Aug 2025.